Aquatic Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Aquatic Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Buy	78,922 +9,839	+14%	+$205K	0.06%	408
2026 Q1	$1.61M	Buy	69,083 +67,040	+3,281%	+$1.46M	0.05%	439
2025 Q4	$42.9K	Buy	+2,043	New	+$35.6K	﹤0.01%	1268
2024 Q4	–	Sell	-6,200	Closed	-$119K	–	1589
2024 Q3	$119K	Buy	+6,200	New	+$128K	﹤0.01%	902
2022 Q1	–	Sell	-500	Closed	-$11K	–	1490
2021 Q4	$11K	Buy	+500	New	+$9.24K	0.02%	776

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Aquatic Capital Management's SNDX Position: Q2 2026 in Review

Aquatic Capital Management increased its Syndax Pharmaceuticals (SNDX) stake by 14% in Q2 2026, buying an estimated $205K and bringing the position to 78,922 shares worth $1.73M. The position accounts for 0.06% of the portfolio, ranked #408.

Aquatic Capital Management first reported a position in SNDX in Q4 2021 and has held it in 5 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Aquatic Capital Management held 78,922 shares of Syndax Pharmaceuticals worth $1.73M as of Q2 2026.
Aquatic Capital Management bought 9,839 Syndax Pharmaceuticals shares in Q2 2026, an estimated $205K.
Syndax Pharmaceuticals made up 0.06% of Aquatic Capital Management's portfolio in Q2 2026, its #408 holding.
Aquatic Capital Management first reported a position in Syndax Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.